Please login to the form below

Not currently logged in
Email:
Password:

Wyeth makes new hires

Wyeth makes two new appointments to its Women's Health Care Business Unit

The pharmaceutical division of Wyeth has appointed Cathy Kerzner to the position of senior vice-president and general manager of the company's Women's Health Care Business Unit.

Kerzner will lead the commercial aspects of Wyeth's portfolio of the unit's products on a global basis and will report to Joseph Mahady, president of global businesses of Wyeth Pharmaceuticals.

She had spent 14 years with Wyeth in a number of commercial capacities before advancing to the position of vice-president of business strategy and then vice-president of commercial strategy for Cardinal Health. Kerzner founded EKR Therapeutics, a US-based start-up specialty pharmaceutical company.

In addition, Wyeth has promoted Dr Michael Dey to the position of president of scientific affairs for women's health. Dey will focus on efforts to advance the understanding of the science that supports both new and existing female healthcare products at the firm. He will also report to Mahady.

Dey joined Wyeth-Ayerst R&D in 1984 and headed Wyeth's generic pharmaceutical business for eight years. Since 2001, he has served as president and general manager of the Women's Health Care arm.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics